JERICHO, N.Y., Nov. 16, 2010 /PRNewswire/ -- Following results of its 12 month study in Europe, Spatz FGIA, Inc. has received regulatory approval for extension of the implantation period from six months to 12 months. Intragastric balloons for weight loss have been used successfully for the last 17 years outside of the US, however, the risk of balloon deflation with subsequent bowel obstruction has mandated removal of all intragastric balloons at six months. The unique anchoring system of the Spatz device protects a deflated balloon from advancing into the intestines, allowing it to be used safely beyond six months.
"While we welcome this extraordinary news, extending the implantation time alone is not enough to produce greater weight loss. Non-adjustable balloons lose their effect within 2 to 4 months, so additional implantation time is not likely to increase weight loss significantly," said Dr. Jeffrey Brooks, founder and CEO of Spatz. "Only an adjustable balloon can offer repeated waves of weight loss, after the balloon volume is adjusted upward," he continued.
The European study has reported an additional 8 kg (17.6 lbs) weight loss following adjustments. In addition, intolerant patients have been successfully adjusted downward, with continued weight loss. Adjustments plus extended implantations have resulted in an average weight loss of 35.5 kg (78 lbs) at the end of one year – achieving loss of 67% of their excess weight. "The potent combination of adjustability and one year implantation is unique to the Spatz device, and will open up a new era in endoscopic weight management," continued Brooks.
"Our gastric balloon specialists have requested adjustability and longer implantation time- and we can now deliver this unique combination," said David Hofstadter, Director of Marketing and Business Development. "We have been overwhelmed with requests from every corner of the planet," he continued, "and we intend to make this